ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.001,60
0,54%
S&P 500
5.127,79
1,26%
Dow Jones
38.675,68
1,18%
Euro vs US Dollar
1,07725
-0,01%
Bitcoin
63.929,13
1,65%
Registration Strip Icon for alerts Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. Oncternal Therapeutics Inc (ONCT)

  7. Oncternal Therapeutics Inc (ONCT) News

ONCT

Oncternal Therapeutics (ONCT)

Oncternal Therapeutics Inc
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:ONCT
DatumZeitQuelleÜberschriftSymbolFirma
08/03/202422h42Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:ONCTOncternal Therapeutics Inc
07/03/202422h20Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:ONCTOncternal Therapeutics Inc
07/03/202422h10Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ONCTOncternal Therapeutics Inc
27/02/202423h02Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ONCTOncternal Therapeutics Inc
16/02/202400h00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ONCTOncternal Therapeutics Inc
16/02/202400h00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ONCTOncternal Therapeutics Inc
16/02/202400h00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ONCTOncternal Therapeutics Inc
16/02/202400h00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ONCTOncternal Therapeutics Inc
23/01/202422h05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ONCTOncternal Therapeutics Inc
05/01/202422h00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ONCTOncternal Therapeutics Inc
05/01/202422h00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ONCTOncternal Therapeutics Inc
05/01/202422h00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ONCTOncternal Therapeutics Inc
05/01/202422h00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ONCTOncternal Therapeutics Inc
05/01/202422h00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ONCTOncternal Therapeutics Inc
09/11/202322h30Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ONCTOncternal Therapeutics Inc
09/11/202322h15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ONCTOncternal Therapeutics Inc
06/10/202322h31Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ONCTOncternal Therapeutics Inc
04/10/202323h01Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ONCTOncternal Therapeutics Inc
04/10/202323h01Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ONCTOncternal Therapeutics Inc
04/10/202322h59Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ONCTOncternal Therapeutics Inc
04/10/202322h59Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ONCTOncternal Therapeutics Inc
14/09/202322h01Edgar (US Regulatory)Form 8-K/A - Current report: [Amend]NASDAQ:ONCTOncternal Therapeutics Inc
10/08/202322h30Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ONCTOncternal Therapeutics Inc
10/08/202322h11Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ONCTOncternal Therapeutics Inc
06/07/202300h59Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ONCTOncternal Therapeutics Inc
06/07/202300h58Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ONCTOncternal Therapeutics Inc
06/07/202300h58Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ONCTOncternal Therapeutics Inc
06/07/202300h57Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ONCTOncternal Therapeutics Inc
30/06/202322h00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ONCTOncternal Therapeutics Inc
30/06/202322h00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ONCTOncternal Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:ONCT

Kürzlich von Ihnen besucht

DBI
TDXP
Tec DAX
NASDAQ
TSLA
Tesla
FX
EURJPY
Euro vs Yen
NYSE
JPM
JP Morgan Chase
CCOM
SILVER
SILVER
NYSE
KO
Coca Cola
NASDAQ
QQQ
Invesco QQQ Trust Series 1
AMEX
SPY
SPDR S&P 500
NASDAQ
NVDA
NVIDIA
CCOM
US500
US 500
USOTC
ADDYY
Adidas (QX)
TG
NOV
Novo Nordisk
TG
DTE
Deutsche Telekom
DBI
DAX
DAX
FX
EURUSD
Euro vs US Dollar
TG
CBK
Commerzbank
Delayed Upgrade Clock
ADVFN Logo

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten